Vascular Solutions Financials

Vascular Solutions Stock Summary

Vascular Solutions competes with Jacobs Solutions, Forsys Metals, Highway Holdings, Calliditas Therapeutics, and Encore Wire. Vascular Solutions, Inc., a medical device company, offer clinical solutions for treating coronary and peripheral vascular disease worldwide.

Vascular Solutions Key Financial Ratios

Generally speaking, Vascular Solutions' financial ratios allow both analysts and investors to convert raw data from Vascular Solutions' financial statements into concise, actionable information that can be used to evaluate the performance of Vascular Solutions over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Vascular Solutions reports annually and quarterly.

Vascular Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Vascular Solutions's current stock value. Our valuation model uses many indicators to compare Vascular Solutions value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vascular Solutions competition to find correlations between indicators driving Vascular Solutions's intrinsic value. More Info.Vascular Solutions is rated first in return on equity category among related companies. It is rated first in return on asset category among related companies reporting about  0.87  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Vascular Solutions is roughly  1.15 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Vascular Solutions by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Vascular Solutions' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vascular Solutions' earnings, one of the primary drivers of an investment's value.

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

If you are still planning to invest in Vascular Solutions check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vascular Solutions' history and understand the potential risks before investing.